- €1.77bn
- €4.56bn
- $3.76bn
- 48
- 93
- 92
- 93
2018 December 31st | 2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,086 | 8,863 | 7,291 | 3,850 | 3,755 |
Cost of Revenue | |||||
Gross Profit | 6,970 | 6,830 | 5,579 | 3,366 | 3,279 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,560 | 6,844 | 6,780 | 2,827 | 2,592 |
Operating Profit | 526 | 2,019 | 511 | 1,023 | 1,163 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -248 | 1,181 | -82 | 464 | 802 |
Provision for Income Taxes | |||||
Net Income After Taxes | -617 | 683 | -395 | 120 | 733 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 582 | 621 | -349 | 674 | -162 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 582 | 621 | -349 | 674 | -162 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.112 | 0.405 | 0.089 | 0.003 | 0.285 |
Dividends per Share |